Team:Trieste

From 2012.igem.org

(Difference between revisions)
Line 37: Line 37:
                         <!-- -->  
                         <!-- -->  
<div class="article">
<div class="article">
-
                             <div class="title"><a href="#">Achievements</a></div>
+
                             <div class="title">Achievements</div>
                             <div class="date"></div>
                             <div class="date"></div>
-
                             <div class="intro"><a href="https://2012.igem.org/Team:Trieste/extra/ach"target="_blank""> Quick link </a> to our judging form and Achievements summary  </div>
+
                             <div class="intro"><a href="https://2012.igem.org/Team:Trieste/extra/ach"target="_blank"> Quick link </a> to our judging form and Achievements summary  </div>
-
    <div class="read_more"><a href="#">a</a></div>
+
    <div class="read_more"><a href="https://2012.igem.org/Team:Trieste/extra/ach"target="_blank">a</a></div>
                         </div>
                         </div>
                          
                          

Revision as of 21:12, 25 September 2012

Our Project

Quick Links

The Team

We present you the Jolly JoCare

Background
Recent studies have evidenced that having a beneficial and healthy intestinal microflora is very important for human health.

Project
Our aim is to modify a bacteria normally found in human gut and create a safe, controllable and versatile molecular platform which can be used to produce a wide range of molecules leading to a beneficial probiotic. For this purpose we have chosen the E. coli strain Nissle 1917 which has been used for many years as a probiotic. We designed a robust gene guard system regulated by a novel and easy to control inducible cumate switch that activates the production of a human antimicrobial peptide LL-37 that can kill the bacteria and also avoid horizontal transfer.

Applications
The safe probiotic constructed here can be used to produce nutritious, preventive or therapeutic molecules. For example, we have used it to produce an antibody against the emerging virus, Norovirus.

Achievements
Quick link to our judging form and Achievements summary
Overview - Have a look to our Jolly JoCare Project at a glance!
Click here to reach our summary page
Team iGEM 2012

Contact us

For other information, write to:

igem2012@gmail.com
Università degli studi di Trieste ICGEB Illy Fondazione Cassa di Risparmio
iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012 iGEM 2012
HTML Hit Counter
google-site-verification: google50e941f54ea0add4.html